Annual Accounts Payable
$2.29 M
-$9.28 M-80.20%
December 1, 2024
Summary
- As of March 10, 2025, XERS annual accounts payable is $2.29 million, with the most recent change of -$9.28 million (-80.20%) on December 1, 2024.
- During the last 3 years, XERS annual accounts payable has fallen by -$6.63 million (-74.34%).
- XERS annual accounts payable is now -80.20% below its all-time high of $11.56 million, reached on December 31, 2023.
Performance
XERS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.29 M
-$5.16 M-69.27%
December 31, 2024
Summary
- As of March 10, 2025, XERS quarterly accounts payable is $2.29 million, with the most recent change of -$5.16 million (-69.27%) on December 31, 2024.
- Over the past year, XERS quarterly accounts payable has stayed the same.
- XERS quarterly accounts payable is now -81.04% below its all-time high of $12.08 million, reached on September 30, 2023.
Performance
XERS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
XERS Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -80.2% | 0.0% |
| 3 y3 years | -74.3% | -81.0% |
| 5 y5 years | -59.1% | -81.0% |
XERS Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -80.2% | at low | -81.0% | at low |
| 5 y | 5-year | -80.2% | at low | -81.0% | at low |
| alltime | all time | -80.2% | +164.4% | -81.0% | +311.9% |
Xeris Biopharma Holdings Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $2.29 M(-69.3%) |
| Dec 2024 | $2.29 M(-80.2%) | - |
| Sep 2024 | - | $7.45 M(+28.5%) |
| Jun 2024 | - | $5.80 M(-18.3%) |
| Mar 2024 | - | $7.09 M(-38.7%) |
| Dec 2023 | $11.56 M(+151.1%) | $11.56 M(-4.2%) |
| Sep 2023 | - | $12.08 M(+3.9%) |
| Jun 2023 | - | $11.62 M(-3.0%) |
| Mar 2023 | - | $11.98 M(+160.2%) |
| Dec 2022 | $4.61 M(-48.4%) | $4.61 M(+17.6%) |
| Sep 2022 | - | $3.92 M(-40.9%) |
| Jun 2022 | - | $6.63 M(-40.2%) |
| Mar 2022 | - | $11.09 M(+24.3%) |
| Dec 2021 | $8.92 M | $8.92 M(+108.0%) |
| Sep 2021 | - | $4.29 M(-17.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $5.18 M(+8.7%) |
| Mar 2021 | - | $4.77 M(+53.0%) |
| Dec 2020 | $3.12 M(-44.4%) | $3.12 M(-33.6%) |
| Sep 2020 | - | $4.69 M(+5.7%) |
| Jun 2020 | - | $4.44 M(+15.6%) |
| Mar 2020 | - | $3.84 M(-31.5%) |
| Dec 2019 | $5.60 M(+547.0%) | $5.60 M(+233.9%) |
| Sep 2019 | - | $1.68 M(-8.8%) |
| Jun 2019 | - | $1.84 M(+30.7%) |
| Mar 2019 | - | $1.41 M(+62.6%) |
| Dec 2018 | $866.00 K(-56.2%) | $866.00 K(+39.2%) |
| Sep 2018 | - | $622.00 K(+11.9%) |
| Jun 2018 | - | $556.00 K(-34.4%) |
| Mar 2018 | - | $847.00 K(-57.1%) |
| Dec 2017 | $1.98 M(+50.3%) | $1.98 M |
| Dec 2016 | $1.31 M | - |
FAQ
- What is Xeris Biopharma Holdings annual accounts payable?
- What is the all time high annual accounts payable for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual accounts payable year-on-year change?
- What is Xeris Biopharma Holdings quarterly accounts payable?
- What is the all time high quarterly accounts payable for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly accounts payable year-on-year change?
What is Xeris Biopharma Holdings annual accounts payable?
The current annual accounts payable of XERS is $2.29 M
What is the all time high annual accounts payable for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual accounts payable is $11.56 M
What is Xeris Biopharma Holdings annual accounts payable year-on-year change?
Over the past year, XERS annual accounts payable has changed by -$9.28 M (-80.20%)
What is Xeris Biopharma Holdings quarterly accounts payable?
The current quarterly accounts payable of XERS is $2.29 M
What is the all time high quarterly accounts payable for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly accounts payable is $12.08 M
What is Xeris Biopharma Holdings quarterly accounts payable year-on-year change?
Over the past year, XERS quarterly accounts payable has changed by $0.00 (0.00%)